Fill and aspirate foam sclerotherapy (FAFS): a new approach for sclerotherapy of large superficial varicosities concomitant to endovenous laser ablation of truncal vein
Aim To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins concomitant to endovenous laser ablation (EVLA). Materials and methods Twenty-seven patients who refused to have phlebectomies with great saphenou...
Saved in:
Published in | Clinical radiology Vol. 70; no. 1; pp. 48 - 53 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.01.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aim To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins concomitant to endovenous laser ablation (EVLA). Materials and methods Twenty-seven patients who refused to have phlebectomies with great saphenous vein reflux and large superficial varicosities were included in the study. Both EVLA and FAFS were performed concomitantly. FAFS is a technique in which all or most of the bubbles and blood–foam mixture are removed from the targeted large varicose veins immediately after the foam has caused sufficient damage to the endothelial cells. Patients were reviewed 1 month and 6 months after the treatment. Improvement in the clinical, aetiological, anatomical, and pathological classification (CEAP), and clinical severity was graded using the revised venous clinical severity score (rVCSS) and cosmetic results were investigated at the 6 month visit. Results Ablation of GSV was performed in 27 limbs in 27 patients (19 males, 70.3%; mean age 44 years; range 21–69 years). All patients had a technically successful FAFS treatment. The CEAP classification score, the rVCSS values, and the cosmetic results showed prominent improvement 6 months after the treatment. There were no significant complications, such as stroke, skin burns, necrosis, paresthesia, deep-vein thrombosis, or allergic reaction. None of the patients experienced neurological events. Conclusion FAFS is a promising safe and effective technique for treating large superficial varicosities concomitant to EVLA of the truncal veins with excellent clinical results. Randomized prospective studies with larger series are required to compare the FAFS with ambulatory phlebectomy and standard foam sclerotherapy. |
---|---|
AbstractList | To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins concomitant to endovenous laser ablation (EVLA).
Twenty-seven patients who refused to have phlebectomies with great saphenous vein reflux and large superficial varicosities were included in the study. Both EVLA and FAFS were performed concomitantly. FAFS is a technique in which all or most of the bubbles and blood-foam mixture are removed from the targeted large varicose veins immediately after the foam has caused sufficient damage to the endothelial cells. Patients were reviewed 1 month and 6 months after the treatment. Improvement in the clinical, aetiological, anatomical, and pathological classification (CEAP), and clinical severity was graded using the revised venous clinical severity score (rVCSS) and cosmetic results were investigated at the 6 month visit.
Ablation of GSV was performed in 27 limbs in 27 patients (19 males, 70.3%; mean age 44 years; range 21-69 years). All patients had a technically successful FAFS treatment. The CEAP classification score, the rVCSS values, and the cosmetic results showed prominent improvement 6 months after the treatment. There were no significant complications, such as stroke, skin burns, necrosis, paresthesia, deep-vein thrombosis, or allergic reaction. None of the patients experienced neurological events.
FAFS is a promising safe and effective technique for treating large superficial varicosities concomitant to EVLA of the truncal veins with excellent clinical results. Randomized prospective studies with larger series are required to compare the FAFS with ambulatory phlebectomy and standard foam sclerotherapy. To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins concomitant to endovenous laser ablation (EVLA). Twenty-seven patients who refused to have phlebectomies with great saphenous vein reflux and large superficial varicosities were included in the study. Both EVLA and FAFS were performed concomitantly. FAFS is a technique in which all or most of the bubbles and blood–foam mixture are removed from the targeted large varicose veins immediately after the foam has caused sufficient damage to the endothelial cells. Patients were reviewed 1 month and 6 months after the treatment. Improvement in the clinical, aetiological, anatomical, and pathological classification (CEAP), and clinical severity was graded using the revised venous clinical severity score (rVCSS) and cosmetic results were investigated at the 6 month visit. Ablation of GSV was performed in 27 limbs in 27 patients (19 males, 70.3%; mean age 44 years; range 21–69 years). All patients had a technically successful FAFS treatment. The CEAP classification score, the rVCSS values, and the cosmetic results showed prominent improvement 6 months after the treatment. There were no significant complications, such as stroke, skin burns, necrosis, paresthesia, deep-vein thrombosis, or allergic reaction. None of the patients experienced neurological events. FAFS is a promising safe and effective technique for treating large superficial varicosities concomitant to EVLA of the truncal veins with excellent clinical results. Randomized prospective studies with larger series are required to compare the FAFS with ambulatory phlebectomy and standard foam sclerotherapy. •Fill and aspirate foam sclerotherapy (FAFS) is a easy and feasible alternative to the ambulatory phlebectomy for the treatment of large superficial varicose veins.•By using FAFS, foam can be prevented from passing into the deep veins.•By using FAFS, endothelium-derived biological mediators as well as the bubles are aspirated from the circulation and this may reduce systemic complications.•The DVT risk may also be decreased due to the aspiration of the pro-coagulant bloodfoam mixture. Aim To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins concomitant to endovenous laser ablation (EVLA). Materials and methods Twenty-seven patients who refused to have phlebectomies with great saphenous vein reflux and large superficial varicosities were included in the study. Both EVLA and FAFS were performed concomitantly. FAFS is a technique in which all or most of the bubbles and blood–foam mixture are removed from the targeted large varicose veins immediately after the foam has caused sufficient damage to the endothelial cells. Patients were reviewed 1 month and 6 months after the treatment. Improvement in the clinical, aetiological, anatomical, and pathological classification (CEAP), and clinical severity was graded using the revised venous clinical severity score (rVCSS) and cosmetic results were investigated at the 6 month visit. Results Ablation of GSV was performed in 27 limbs in 27 patients (19 males, 70.3%; mean age 44 years; range 21–69 years). All patients had a technically successful FAFS treatment. The CEAP classification score, the rVCSS values, and the cosmetic results showed prominent improvement 6 months after the treatment. There were no significant complications, such as stroke, skin burns, necrosis, paresthesia, deep-vein thrombosis, or allergic reaction. None of the patients experienced neurological events. Conclusion FAFS is a promising safe and effective technique for treating large superficial varicosities concomitant to EVLA of the truncal veins with excellent clinical results. Randomized prospective studies with larger series are required to compare the FAFS with ambulatory phlebectomy and standard foam sclerotherapy. AIMTo define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins concomitant to endovenous laser ablation (EVLA).MATERIALS AND METHODSTwenty-seven patients who refused to have phlebectomies with great saphenous vein reflux and large superficial varicosities were included in the study. Both EVLA and FAFS were performed concomitantly. FAFS is a technique in which all or most of the bubbles and blood-foam mixture are removed from the targeted large varicose veins immediately after the foam has caused sufficient damage to the endothelial cells. Patients were reviewed 1 month and 6 months after the treatment. Improvement in the clinical, aetiological, anatomical, and pathological classification (CEAP), and clinical severity was graded using the revised venous clinical severity score (rVCSS) and cosmetic results were investigated at the 6 month visit.RESULTSAblation of GSV was performed in 27 limbs in 27 patients (19 males, 70.3%; mean age 44 years; range 21-69 years). All patients had a technically successful FAFS treatment. The CEAP classification score, the rVCSS values, and the cosmetic results showed prominent improvement 6 months after the treatment. There were no significant complications, such as stroke, skin burns, necrosis, paresthesia, deep-vein thrombosis, or allergic reaction. None of the patients experienced neurological events.CONCLUSIONFAFS is a promising safe and effective technique for treating large superficial varicosities concomitant to EVLA of the truncal veins with excellent clinical results. Randomized prospective studies with larger series are required to compare the FAFS with ambulatory phlebectomy and standard foam sclerotherapy. |
Author | Atasoy, M.M |
Author_xml | – sequence: 1 fullname: Atasoy, M.M |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25446324$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1uEzEUhS1URNPCC7BAXpZFgv9mEiNUqapIQarEoiCxs27sO9RhYg-2JyhvxGPWoxQWXbCyrvSdI99z7hk5CTEgIa85W3DG23fbhU3gFoJxtWB6wbh8RmZcts1cCP39hMwYY3quRctOyVnO22lUQr0gp6JRqpVCzcifte97CsFRyINPUJB2EXY02x5TLPeYYDjQi_XV-u7tewo04G8Kw5Ai2PtKpidg7GgP6QfSPA6YOm899HQPyduYffGYqY3Bxp0vEAotkWJwcY8hjrkKMyYKmx6Kj2GyKmkMdjJAH16S5x30GV89vufk2_rj1-tP89svN5-vr27nVnFe5lxwtXTSOQd6s5FyJfVKLtFqZgXnorEKW2iFdqC6VrVcwGojQOqlUyvXNFqek4ujb93x14i5mJ3PFvseAtZfGt7KZbOUjIuKiiNqU8w5YWeG5HeQDoYzMzVktmZqyEwNGaZNbaiK3jz6j5sdun-Sv5VU4MMRwLrl3mMy2XoMFp1PaItx0f_f__KJ3PY--BrjTzxg3sYxhZqf4SYLw8zddBTTiXDFmFI1rAf8x7tl |
CitedBy_id | crossref_primary_10_1007_s12325_019_01011_7 |
Cites_doi | 10.1258/phleb.2010.010030 10.1016/j.ejvs.2006.09.005 10.1016/j.jvsv.2012.10.040 10.1258/phleb.2012.012s09 10.1258/phleb.2011.010098 10.1016/j.ejvs.2013.07.013 10.1258/phleb.2009.009049 10.1177/0268355513483280 10.1016/j.jvs.2010.06.161 10.1007/s00270-012-0366-4 10.1258/phleb.2012.012051 |
ContentType | Journal Article |
Copyright | The Royal College of Radiologists 2014 The Royal College of Radiologists Copyright © 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: The Royal College of Radiologists – notice: 2014 The Royal College of Radiologists – notice: Copyright © 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.crad.2014.09.013 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-229X |
EndPage | 53 |
ExternalDocumentID | 10_1016_j_crad_2014_09_013 25446324 S0009926014004498 1_s2_0_S0009926014004498 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29B 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAWTL AAXKI AAXUO ABBQC ABFNM ABJNI ABMAC ABMZM ABXDB ACDAQ ACGFS ACRLP ADBBV ADEZE AEBSH AEKER AENEX AEVXI AFCTW AFFNX AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEI HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM M27 M41 MO0 N9A O-L O9- OAUVE OI~ OU0 OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K TEORI UHS UV1 WH7 WUQ X7M Z5R ZGI ZXP ~G- AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c411t-12147d3ddda9bb33839837ec90c21125c4e6a629da4f64612a8b2a397d48d5593 |
IEDL.DBID | AIKHN |
ISSN | 0009-9260 |
IngestDate | Fri Oct 25 05:11:01 EDT 2024 Thu Sep 26 15:41:33 EDT 2024 Sat Sep 28 08:06:38 EDT 2024 Fri Feb 23 02:24:30 EST 2024 Tue Oct 15 14:33:59 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Copyright © 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c411t-12147d3ddda9bb33839837ec90c21125c4e6a629da4f64612a8b2a397d48d5593 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 25446324 |
PQID | 1637573012 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1637573012 crossref_primary_10_1016_j_crad_2014_09_013 pubmed_primary_25446324 elsevier_sciencedirect_doi_10_1016_j_crad_2014_09_013 elsevier_clinicalkeyesjournals_1_s2_0_S0009926014004498 |
PublicationCentury | 2000 |
PublicationDate | 2015-01-01 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – month: 01 year: 2015 text: 2015-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Clinical radiology |
PublicationTitleAlternate | Clin Radiol |
PublicationYear | 2015 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Fattahi (bib5) 2013; 1 Parsi (bib11) 2011; 26 Breu, Guggenbichler, Wollmann (bib10) 2008; 37 Parsi (bib3) 2012; 27 Yilmaz, Ceken, Alimoglu (bib7) 2013; 36 Cameron, Chen, Connor (bib13) 2013; 46 Imhoff, Stemmer (bib14) 1969; 22 Guexx (bib9) 2009; 24 Willenberg, C Smith, Shepherd (bib4) 2013 Cavezzi, Parsi (bib1) 2012; 27 Vasquez, Rabe, McLafferty (bib6) 2010; 52 Rabe, Breu, Cavezzi (bib8) 2013; 29 Connor, Joseph, Exner (bib2) 2013 Myers, Jolley, Clough (bib12) 2007; 33 Rabe (10.1016/j.crad.2014.09.013_bib8) 2013; 29 Cameron (10.1016/j.crad.2014.09.013_bib13) 2013; 46 Vasquez (10.1016/j.crad.2014.09.013_bib6) 2010; 52 Parsi (10.1016/j.crad.2014.09.013_bib11) 2011; 26 Imhoff (10.1016/j.crad.2014.09.013_bib14) 1969; 22 Guexx (10.1016/j.crad.2014.09.013_bib9) 2009; 24 Yilmaz (10.1016/j.crad.2014.09.013_bib7) 2013; 36 Cavezzi (10.1016/j.crad.2014.09.013_bib1) 2012; 27 Breu (10.1016/j.crad.2014.09.013_bib10) 2008; 37 Willenberg (10.1016/j.crad.2014.09.013_bib4) 2013 Fattahi (10.1016/j.crad.2014.09.013_bib5) 2013; 1 Connor (10.1016/j.crad.2014.09.013_bib2) 2013 Parsi (10.1016/j.crad.2014.09.013_bib3) 2012; 27 Myers (10.1016/j.crad.2014.09.013_bib12) 2007; 33 |
References_xml | – volume: 52 start-page: 1387 year: 2010 end-page: 1396 ident: bib6 article-title: Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American VenousForum Ad Hoc Outcomes Working Group publication-title: J Vasc Surg contributor: fullname: McLafferty – volume: 27 start-page: 46 year: 2012 end-page: 51 ident: bib1 article-title: Complications of foam sclerotherapy publication-title: Phlebology contributor: fullname: Parsi – volume: 37 start-page: 1 year: 2008 end-page: 29 ident: bib10 article-title: 2nd European consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany publication-title: Vasa contributor: fullname: Wollmann – volume: 1 start-page: 111 year: 2013 end-page: 112 ident: bib5 article-title: Foam washout sclerotherapy: a new technique geared toward reducing short- and long-term complications of regular foam sclerotherapy and comparison with existing foam sclerotherapy method publication-title: J Vasc Surg Venous Lymph Dısord contributor: fullname: Fattahi – volume: 24 start-page: 270 year: 2009 end-page: 274 ident: bib9 article-title: Complications and side-effects of foam sclerotherapy publication-title: Phlebology contributor: fullname: Guexx – volume: 33 start-page: 116 year: 2007 end-page: 121 ident: bib12 article-title: Outcome of ultrasound guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance publication-title: Eur J Vasc Endovasc Surg contributor: fullname: Clough – volume: 22 start-page: 143 year: 1969 ident: bib14 article-title: Classification and mechanism of action of sclerosing agents publication-title: Soc Fran Phlebol contributor: fullname: Stemmer – year: 2013 ident: bib4 article-title: Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review publication-title: Phlebology contributor: fullname: Shepherd – volume: 46 start-page: 488 year: 2013 end-page: 494 ident: bib13 article-title: Sclerosant foam structure and stability is strongly influenced by liquid air fraction publication-title: Eur J Vasc Endovasc Surg contributor: fullname: Connor – volume: 36 start-page: 150 year: 2013 end-page: 157 ident: bib7 article-title: US-guided femoral and sciatic nerve blocks for analgesia during endovenous laser ablation publication-title: Cardiovasc Intervent Radiol contributor: fullname: Alimoglu – volume: 27 start-page: 147 year: 2012 end-page: 167 ident: bib3 article-title: Paradoxical embolism, stroke and sclerotherapy publication-title: Phlebology contributor: fullname: Parsi – year: 2013 ident: bib2 article-title: Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels publication-title: Phlebology contributor: fullname: Exner – volume: 29 start-page: 338 year: 2013 end-page: 354 ident: bib8 article-title: European guidelines for sclerotherapy in chronic venous disorders publication-title: Phlebology contributor: fullname: Cavezzi – volume: 26 start-page: 140 year: 2011 end-page: 147 ident: bib11 article-title: Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications publication-title: Phlebology contributor: fullname: Parsi – volume: 22 start-page: 143 year: 1969 ident: 10.1016/j.crad.2014.09.013_bib14 article-title: Classification and mechanism of action of sclerosing agents publication-title: Soc Fran Phlebol contributor: fullname: Imhoff – volume: 26 start-page: 140 year: 2011 ident: 10.1016/j.crad.2014.09.013_bib11 article-title: Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications publication-title: Phlebology doi: 10.1258/phleb.2010.010030 contributor: fullname: Parsi – volume: 33 start-page: 116 year: 2007 ident: 10.1016/j.crad.2014.09.013_bib12 article-title: Outcome of ultrasound guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance publication-title: Eur J Vasc Endovasc Surg doi: 10.1016/j.ejvs.2006.09.005 contributor: fullname: Myers – year: 2013 ident: 10.1016/j.crad.2014.09.013_bib2 article-title: Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels publication-title: Phlebology contributor: fullname: Connor – volume: 1 start-page: 111 year: 2013 ident: 10.1016/j.crad.2014.09.013_bib5 article-title: Foam washout sclerotherapy: a new technique geared toward reducing short- and long-term complications of regular foam sclerotherapy and comparison with existing foam sclerotherapy method publication-title: J Vasc Surg Venous Lymph Dısord doi: 10.1016/j.jvsv.2012.10.040 contributor: fullname: Fattahi – volume: 37 start-page: 1 issue: Suppl. 71 year: 2008 ident: 10.1016/j.crad.2014.09.013_bib10 article-title: 2nd European consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany publication-title: Vasa contributor: fullname: Breu – volume: 27 start-page: 46 year: 2012 ident: 10.1016/j.crad.2014.09.013_bib1 article-title: Complications of foam sclerotherapy publication-title: Phlebology doi: 10.1258/phleb.2012.012s09 contributor: fullname: Cavezzi – volume: 27 start-page: 147 year: 2012 ident: 10.1016/j.crad.2014.09.013_bib3 article-title: Paradoxical embolism, stroke and sclerotherapy publication-title: Phlebology doi: 10.1258/phleb.2011.010098 contributor: fullname: Parsi – volume: 46 start-page: 488 year: 2013 ident: 10.1016/j.crad.2014.09.013_bib13 article-title: Sclerosant foam structure and stability is strongly influenced by liquid air fraction publication-title: Eur J Vasc Endovasc Surg doi: 10.1016/j.ejvs.2013.07.013 contributor: fullname: Cameron – volume: 24 start-page: 270 year: 2009 ident: 10.1016/j.crad.2014.09.013_bib9 article-title: Complications and side-effects of foam sclerotherapy publication-title: Phlebology doi: 10.1258/phleb.2009.009049 contributor: fullname: Guexx – volume: 29 start-page: 338 year: 2013 ident: 10.1016/j.crad.2014.09.013_bib8 article-title: European guidelines for sclerotherapy in chronic venous disorders publication-title: Phlebology doi: 10.1177/0268355513483280 contributor: fullname: Rabe – volume: 52 start-page: 1387 year: 2010 ident: 10.1016/j.crad.2014.09.013_bib6 article-title: Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American VenousForum Ad Hoc Outcomes Working Group publication-title: J Vasc Surg doi: 10.1016/j.jvs.2010.06.161 contributor: fullname: Vasquez – volume: 36 start-page: 150 year: 2013 ident: 10.1016/j.crad.2014.09.013_bib7 article-title: US-guided femoral and sciatic nerve blocks for analgesia during endovenous laser ablation publication-title: Cardiovasc Intervent Radiol doi: 10.1007/s00270-012-0366-4 contributor: fullname: Yilmaz – year: 2013 ident: 10.1016/j.crad.2014.09.013_bib4 article-title: Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review publication-title: Phlebology doi: 10.1258/phleb.2012.012051 contributor: fullname: Willenberg |
SSID | ssj0009424 |
Score | 2.1232874 |
Snippet | Aim To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins... To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins... AIMTo define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 48 |
SubjectTerms | Adult Aged Feasibility Studies Female Humans Laser Therapy - methods Male Middle Aged Radiology Retrospective Studies Saphenous Vein - surgery Sclerotherapy - methods Treatment Outcome Varicose Veins - therapy Young Adult |
Title | Fill and aspirate foam sclerotherapy (FAFS): a new approach for sclerotherapy of large superficial varicosities concomitant to endovenous laser ablation of truncal vein |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0009926014004498 https://dx.doi.org/10.1016/j.crad.2014.09.013 https://www.ncbi.nlm.nih.gov/pubmed/25446324 https://search.proquest.com/docview/1637573012 |
Volume | 70 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61Wwn1gniWpVC5EgcQCl0nTjbmtqqIFqr2ApV6s_yKlGpJVpulEpf-nv7MzqydIkDlwDGRH4lnPA975huAN1lNl2EFYexbmwh0vxKZp0XCDWpjXXhR15QofHpWzM_Fl4v8YguOh1wYCquMsj_I9I20jm-O4moeLZuGcnzRuiFELGJDIctt2EF1lJYj2Jl9Ppmf_cLeFakYCqpRh5g7E8K87EoTYCgPcKc8u08_3Wd_bvRQ9QgeRgOSzcI3PoYt3z6BB6fxivwp3FTNYsF065gOl-ie1Z3-znpsvYrpVj_Z22pWfX33kWmGZjUbgMWx5eqPhl3NFhQszvofSypoTSfs7AodbLuJ9vI9Q4caF6-hasRs3THfuu5qA_yKHZG_mTYh3I6GWq9QjdIAvmmfwXn16dvxPInlGBIrOF8nnEoaucw5p6Ux5NpK9G69lROLXmSaW-ELXaTSaVEXAi0nXZpUo73jROnQccmew6jtWv8CcObCWj-1dakz4SfO1JnJMy3l1AjDuRzD-4EIahlQN9QQjnapiGSKSKYmUiHJxjAd6KSGfFKUgL6P27FXXPWpmqi_WGYM-V3P37hOoUL554yHAzso3I50x6Jbjyur0Lyd5iQ10zHsBT65-wNCgyN0_Jf_Oes-7OJTHg6AXsEIaeZfo0m0Ngew_eGaH0TGvwWvSgwG |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTQJeEOOzwDYj8QBC0erESWveqmlRx9a-sEl7s_wVKagkVVMm8R_xZ3JXO0MwbQ97be249Z3vfhff_Q7gQ1bRZVhBHPvWJgLDr0TmaZFwg95YF15UFRUKz-bF9EJ8vcwvt-Cor4WhtMpo-4NN31jr-Mlh3M3DZV1TjS-iG2LEIjUUcvwAdhANSDydO5OT0-n8L_euSEXfUI0mxNqZkOZlV5oIQ3mgO-XZbf7pNvy58UPlU3gSASSbhN-4C1u-eQYPZ_GK_Dn8LuvFgunGMR0u0T2rWv2DdTh6FcutfrGP5aT89ukL0wxhNeuJxXHk6r-BbcUWlCzOup9LamhNb9jZFQbYdpPt5TuGATVuXk3diNm6Zb5x7dWG-BUnon4zbUK6HT1qvUI3Sg_wdfMCLsrj86NpEtsxJFZwvk44tTRymXNOS2MotJUY3XorhxajyDS3whe6SKXToioEIic9NqlGvOPE2GHgkr2E7aZt_GvAlQtr_chWY50JP3SmykyeaSlHRhjO5QA-90JQy8C6ofp0tO-KRKZIZGooFYpsAKNeTqqvJ0UL6Lt4HDvFVZeqobqhMgPIr2f-o3UKHcqdK77v1UHhcaQ7Ft143FmF8HaUk9VMB_Aq6Mn1PyA2OGLHf3PPVQ_g0fR8dqbOTuanb-ExfpOHl0HvYBvl5_cQHq3NflT_Pyj0Dfo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fill+and+aspirate+foam+sclerotherapy+%28FAFS%29%3A+a+new+approach+for+sclerotherapy+of+large+superficial+varicosities+concomitant+to+endovenous+laser+ablation+of+truncal+vein&rft.jtitle=Clinical+radiology&rft.au=Atasoy%2C+M.M&rft.date=2015-01-01&rft.issn=0009-9260&rft.volume=70&rft.issue=1&rft.spage=48&rft.epage=53&rft_id=info:doi/10.1016%2Fj.crad.2014.09.013&rft.externalDBID=ECK1-s2.0-S0009926014004498&rft.externalDocID=1_s2_0_S0009926014004498 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00099260%2FS0009926014X00139%2Fcov150h.gif |